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A B S T R A C T
Background: Transcranial magnetic stimulation (TMS) is a non-invasive brain stimulation technique that has
shown promise as an adjunct treatment for the symptoms of Obsessive-Compulsive Disorder (OCD). Establishing
a clear clinical role for TMS in the treatment of OCD is contingent upon evidence of signiﬁcant eﬃcacy and
reliability in reducing symptoms.
Objectives: We present the basic principles supporting the eﬀects of TMS on brain activity with a focus on
network-based theories of brain function. We discuss the promises and pitfalls of this technique as a means of
modulating brain activity and reducing OCD symptoms.
Methods: Synthesis of trends and critical perspective on the potential beneﬁts and limitations of TMS inter-
ventions in OCD.
Findings: Our critical synthesis suggests the need to better quantify the role of TMS in a clinical setting. The
context in which the stimulation is performed, the neural principles supporting the eﬀects of local stimulation on
brain networks, and the heterogeneity of neuroanatomy are often overlooked in the clinical application of TMS.
The lack of consideration of these factors may partly explain the variable eﬃcacy of TMS interventions for OCD
symptoms.
Conclusions: Results from existing clinical studies and emerging knowledge about the eﬀects of TMS on brain
networks are encouraging but also highlight the need for further research into the use of TMS as a means of
selectively normalising OCD brain network dynamics and reducing related symptoms. The combination of
neuroimaging, computational modelling, and behavioural protocols known to engage brain networks aﬀected by
OCD has the potential to improve the precision and therapeutic eﬃcacy of TMS interventions. The eﬃcacy of
this multimodal approach remains, however, to be established and its eﬀective translation in clinical contexts
presents technical and implementation challenges. Addressing these practical, scientiﬁc and technical issues is
required to assess whether OCD can take its place alongside major depressive disorder as an indication for the
use of TMS.
1. Introduction
Obsessive-Compulsive Disorder (OCD) is a severe mental illness that
aﬀects 1–3% of the population (Stein et al., 1997; Ruscio et al., 2010).
The phenomenology of OCD maps onto two main domains: obsessions
(recurring and intrusive thoughts) and compulsions (ritualistic beha-
viours performed to reduce anxiety). OCD manifests as a heterogeneous
clinical condition with the intensity and mix of obsessions and com-
pulsions varying between patients (Harrison et al., 2013). Moreover,
the clinical presentation of OCD is often associated with comorbid
symptoms of general anxiety or depression (Overbeek et al., 2002).
OCD may therefore represent a broad constellation of distinct syn-
dromes and clinical phenotypes.
Similar to other psychiatric conditions, the diagnosis of OCD in primary
care and psychiatric settings is often missed, late or erroneous (Glazier et al.,
2013; Veldhuis et al., 2012). Moreover, data suggests that even when an
appropriate diagnosis is made,<10% of patients receive a disorder-speciﬁc
treatment that is evidence-based (Torres et al., 2007).
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Current evidence supports the use of cognitive behavioural thera-
pies (cognitive reappraisal and exposure interventions) and selective
serotonin reuptake inhibitor (SSRIs) drugs as a ﬁrst line treatment for
OCD (Hirschtritt et al., 2017). Although pharmacological and beha-
vioural interventions are eﬀective treatments for OCD (Hirschtritt et al.,
2017), over 40% of patients remain clinically symptomatic and highly
disabled for decades after initial treatment (Bloch et al., 2006; Pallanti
and Quercioli, 2006). Therefore, there is a pressing need to develop
new eﬃcacious, safe, and tolerable therapies to reduce the extreme
burden of the disorder.
Transcranial magnetic stimulation (TMS) is an emerging non-in-
vasive brain stimulation technique that has an established therapeutic
role in major depressive disorder (MDD) (Kedzior et al., 2015;
O'Reardon et al., 2007; Fitzgerald et al., 2003; Fitzgerald et al., 2006;
Fitzgerald et al., 2009; George et al., 2010; George and Post, 2011). In
particular, repetitive TMS (rTMS) has been approved by the American
FDA regulatory authorities as a therapeutic intervention for symptoms
of MDD in patients that failed to respond to at least one or two courses
of pharmacological treatment (Horvath et al., 2010; Connolly et al.,
2012). Speciﬁcally, rTMS has a role in the treatment of an acute de-
pressive episode (O'Reardon et al., 2007; Fitzgerald et al., 2003) as well
as in maintenance therapy (O'Reardon et al., 2005). Because of its ef-
ﬁcacy [mean eﬀect size of 0.55 of active vs placebo TMS, (Slotema
et al., 2010)] and favourable safety proﬁle (George and Post, 2011),
TMS has obtained a deﬁnitive clinical role in both the private and
public psychiatry sectors.
More recently, research has suggested that TMS holds potential to ef-
fectively complement existing behavioural and pharmacological therapies
for OCD [for examples of existing studies see Table 1; for recent systematic
reviews see (Blom et al., 2011; Berlim et al., 2013; Saba et al., 2015;
Trevizol et al., 2016)]. In this perspective, we provide a brief introduction to
the eﬀects of TMS on brain activity, highlighting the promises and pitfalls of
this technique as a viable therapeutic intervention for OCD. Currently, TMS
is largely administered as a one size ﬁts all therapy, without customising the
choice of cortical stimulation according to a patient's speciﬁc clinical proﬁle
or imaging-based estimates of dysregulation of cortical network activity.
The overarching aim of this paper is to consider the potential beneﬁts of
personalizing the administration of TMS interventions by means of each
patient's symptom proﬁle, neuroanatomical architecture and brain con-
nectivity dysfunction across diﬀerent mental states. We contend that the
eﬃcacy of TMS as a therapy for OCD can be improved by: i) understanding
the mechanisms, timescales and network principles by which TMS mod-
ulates state dependent functional brain connectivity; and ii) personalizing
TMS therapy by selecting cortical stimulation sites and other stimulation
parameters according to each patient's symptom proﬁle and state-speciﬁc
brain connectivity dysfunction. We provide practical suggestions about how
the use of TMS can be optimized in clinical settings.
2. Transcranial magnetic stimulation (TMS)
2.1. Principles and local eﬀects of TMS
TMS is a non-invasive brain stimulation technique that alters the
activity of neurons within a targeted cortical region (Hallett, 2000;
Hallett, 2007). TMS is administered using a wire coil. During stimula-
tion, a brief high-current is produced in the magnetic coil, generating a
relatively strong magnetic ﬁeld (up to several Tesla) that lasts for ap-
proximatively 100 microseconds (Hallett, 2007). This creates lines of
magnetic ﬂux that orientate perpendicularly to the plane of the wire
coil. The ﬂux then in turn induces an electric ﬁeld perpendicular to the
magnetic ﬁeld, as determined by electromagnetic induction princi-
ples described by Michael Faraday in the nineteenth century. Rapidly
changing magnetic ﬁelds induce electrical currents that can depolarise
superﬁcial axons and activate local neural circuits. The extent to which
TMS generates these intra-cortical currents depends on multiple factors
including the type and orientation of the coil, the frequency of
stimulation, and the distance between the brain and the coil
(Lefaucheur et al., 2014). Some of these factors can be controlled: For
example, the shape of the magnetic coil can be changed to achieve
strong but diﬀuse stimulation (i.e., round coils) or focal stimulation
(i.e., ﬁgure-of-eight).
The local eﬀects of TMS have been extensively studied, particularly in the
motor system (Bohning et al., 1999; Huang et al., 2005; de Lara et al., 2017;
Murphy et al., 2016). The motor system is easily accessible for TMS and also
allows for a precise behavioural assessment of the eﬀect of the stimulation
through measuring the induced twitching of a muscle activated through sti-
mulation of the contralateral motor cortex. In fact, the recording of motor
evoked potentials (MEP) immediately following TMS allows one to assess
both the location and eﬀect of the stimulation on the motor cortex functional
architecture (Wassermann et al., 1992). As we will discuss in the following
paragraph, TMS can also be used to change cortical excitability. In this
context, increases in the threshold of stimulation required to evoke a MEP
after TMS are generally thought to indicate an inhibitory eﬀect of stimulation
whereas a lower stimulation threshold suggests an excitatory eﬀect (Hallett,
2000; Huang et al., 2005). A common complementary measure to assess the
neural eﬀects of TMS is the change in the recruitment-curve slope [i.e.,
change in the MEP amplitude as a function of stimulus intensity, (Hallett,
2000)].
A number of stimulation protocols have been shown to increase or in-
hibit cortical activity for periods that outlast the duration of the stimulation
(Lefaucheur et al., 2014). Due to this persisting eﬀect, these paradigms have
received the attention of clinical researchers interested in modulating the
activity of a region, or network of regions, in disorders like MDD (Fox et al.,
2012) and OCD (Berlim et al., 2013). High-frequency repetitive TMS
(5–20Hz) has been shown to increase cortical excitability whereas low
frequency (1Hz) repetitive TMS decreases cortical excitability (Chen et al.,
1997; Pascual-Leone et al., 1994). More recently, shorter (~40–190 s) sti-
mulation protocols have been developed to induce excitatory (intermittent
theta burst stimulation, iTBS) and inhibitory (continuous theta burst
stimulation, cTBS) eﬀects which have been shown to last for over 60min
(see glossary, Huang et al., 2005). Several factors including BDNF poly-
morphism, the number of pulses, and the frequency of stimulation may
inﬂuence the eﬀect of TBS paradigms (Chung et al., 2016). Although further
research is needed to improve the eﬃcacy and reliability of TBS paradigms,
compared to low and high frequency TMS protocols, TBS adopts a lower
stimulation intensity (70% compared to 100% of resting motor threshold)
and has a shorter duration (~1-3min versus 15–20min). Therefore, the
application of TBS protocols is more easily tolerated by participants, par-
ticularly in the clinical setting, compared to more conventional repetitive
TMS protocols. Importantly, a recent randomised, multicentre, non-in-
feriority clinical trial reported that the eﬃcacy of iTBS to the left DLPFC in
reducing symptoms of MDD is comparable to the one achieved by the
longer 10Hz rTMS protocol (Blumberger et al., 2018). This result suggests
that high-frequency rTMS and iTBS have a similar eﬀect on brain dynamics
underpinning symptoms of depression.
Stimulation intensity for rTMS and TBS protocols is often titrated
against the minimum intensity required to elicit a motor response
when stimulating the motor cortex, known as the motor threshold.
Determining the motor threshold for repetitive TMS can be performed
visually or using electromyography (EMG). Visually, a common method
is to deﬁne the motor threshold according to the lowest stimulation
intensity needed to observe a movement on the targeted hand muscle in
at least 5 out of 10 trials. Using EMG, the resting motor threshold can be
deﬁned as the lowest setting to generate ≥5 out of 10 MEPs (≥50 μV
peak to peak). Given that safety guidelines for TMS have been devel-
oped using the EMG method and evidence suggests that the visual
method overestimates the motor threshold (Westin et al., 2014), the use
of EMG is advised for clinical interventions.
A quadripulse magnetic stimulation (QPS) protocol that involves
delivering repetitive bursts of four monophasic TMS pulses applied at
very short inter-pulse intervals has also been recently developed
(Hamada et al., 2008; Hanajima et al., 2017). This recent stimulation
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protocol is based on theories of metaplasticity (see Section 3.2.) and has
been proposed to improve the reliability of eﬀects on MEP. However,
these ﬁndings require replication. Moreover, its use outside the motor
system has been limited and as such, this protocol has not yet been used
for clinical research.
The use of TMS has not been conﬁned to the sensorimotor system, but
has also been used extensively to alter local brain activity and thus assess
the contribution of targeted brain regions to various perceptual and cog-
nitive functions (Walsh and Cowey, 2000; Polanía et al., 2018) including
visual attention (Chambers et al., 2004). Unlike the motor cortex, stimu-
lation of high-order associative brain regions such as the orbitofrontal
cortex (OFC) does not have a direct response that can be easily validated in
order to demonstrate the impact of stimulating OFC circuits. However,
neuroimaging techniques, such as functional magnetic resonance imaging
(fMRI) or electroencephalography (EEG), have been used to assess the im-
pact of stimulation on brain activity (Ruﬀ et al., 2006; Bestmann et al.,
2005; Chung et al., 2016). In addition to characterising the eﬀects of tar-
geted TMS on local brain regions, functional neuroimaging data has high-
lighted the impact of local brain stimulation on the activity of widespread
neural networks throughout the brain (Sale et al., 2015; Bortoletto et al.,
2015).
2.2. Network eﬀects of local TMS
The brain can be conceptualised as a complex network, with neurons
connected locally into circuits and, through long-range anatomical projec-
tions, circuits connected into systems (Park and Friston, 2013; Sporns, 2011;
Fornito et al., 2016). Structural networks are those constituted by direct
anatomical connections, whereas functional connectivity denotes the
correlated activity that these structural networks support (see glossary,
Honey et al., 2007; Hermundstad et al., 2013; Cocchi et al., 2014). At the
macroscopic scale, the organization of functional brain networks can be
characterised using neuroimaging techniques such as positron emission
tomography (PET) and functional magnetic resonance imaging (fMRI).
An increasing number of fMRI-based ﬁndings show that rTMS protocols can
evoke changes in neural activity and functional connectivity between re-
mote brain regions (Ruﬀ et al., 2008; Ruﬀ et al., 2006; Cocchi et al., 2016;
Cocchi et al., 2015; Bestmann et al., 2005; Eldaief et al., 2011). For ex-
ample, the stimulation of a frontal brain region involved in high-level visual
processes (i.e., the frontal eye ﬁelds, FEF) can alter activity in, and con-
nectivity between, early visual areas (Ruﬀ et al., 2006; Cocchi et al., 2016).
Importantly, this neurophysiological eﬀect has been related to distinct
changes in visual perception (Ruﬀ et al., 2006). In the clinical setting, it has
been shown that the eﬀect of prefrontal stimulation to reduce symptoms of
major depression may be related to the baseline (resting-state) level of
functional connectivity between the targeted prefrontal region and the
subgenual cingulate (Fox et al., 2012). These results highlight the im-
portance of target selection when determining an appropriate TMS protocol.
This emerging body of multimodal work, also emphasizes the signiﬁcance
of considering the eﬀects of local TMS on whole-brain functional networks
and supports the proposal that targeted TMS could redress abnormal pat-
terns of neuronal network activity underpinning brain disorders (Fornito
et al., 2015; Sale et al., 2015).
3. TMS as a potential intervention to alleviate symptoms of OCD
3.1. Dysfunctional brain networks in OCD
The application of TMS to therapeutically modulate brain network ac-
tivity in OCD is contingent upon knowledge about the maladaptive brain
activity that underlies the expression of OCD symptoms (Sale et al., 2015).
Changes in “resting-state” (glossary) functional network activity in those with
OCD provide useful goalposts. Analyzing resting-state activity has provided
substantial utility in mapping the brain's functional network architecture and
is not contingent on patient compliance in engaging a challenging task
(Power et al., 2011). Moreover, resting-state brain activity has also been
shown to predict task-induced neural activity (Cole et al., 2016), a broad
range of behavioural performances (Smith et al., 2015), and psychopathology
(Drysdale et al., 2017; Cocchi et al., 2012a; Lin et al., 2018).
Increased resting-state functional connectivity between striatal and
prefrontal brain regions —including the OFC and the frontal pole — is
one of the most consistent ﬁndings in OCD [(Harrison et al., 2013;
Harrison et al., 2009; Hou et al., 2014; Sakai et al., 2011; Figee et al.,
2013), although see (Posner et al., 2014)]. Furthermore, the degree of
hyper-connectivity between the striatum and the prefrontal cortex is
linearly associated with symptom severity (Harrison et al., 2009; Figee
et al., 2013) (Fig. 1).
While resting-state networks provide potential targets for TMS
Fig. 1. Results from a study showing that invasive deep brain stimulation (DBS) of the left (red) and right (blue) ventral striatum (nucleus accumbens) modulated
frontostriatal connectivity in the resting-state and while patients rated neutral or symptoms-provoking visual images (Figee et al., 2013). Resting-state functional
neuroimaging results showed that DBS reduced functional connectivity between the ventral striatum and the prefrontal cortex (red and blue, with purple indicating
overlap). Reductions in OCD symptoms (Y-BOCS) linearly correlated with DBS-induced changes in connectivity between the left ventral stiatum and the lateral
prefrontal cortex (r=0.72). Notably, DBS also modulated low frequency EEG oscillations in response to symptoms provoking stimuli (not shown). Reproduced with
permission from (Figee et al., 2013).
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interventions in OCD, altered neural network activity during speciﬁc
task performance may highlight state-dependent dysregulations that
are speciﬁc to deﬁned symptoms. For example, patients with OCD show
increased task-induced connectivity in a brain network comprising the
anterior insula-frontal operculum and the dorsal anterior cingulate
when asked to engage in a cognitive task (Cocchi et al., 2012b) (Fig. 2).
Importantly, this induced hyper-connectivity in the anterior insula-
frontal operculum (salience network) was positively correlated with
scores on the Beck Anxiety Inventory (r=0.49, BAI). On the other
hand, exposure to obsession-inducing images appears to exacerbate
brain activity in the anterior cingulate and mid-orbitofrontal cortices
(Morgiève et al., 2014). These diﬀerent patterns of brain activity in
OCD patients across diﬀerent tasks highlight the importance of
considering the context in which TMS is administered. In sum, brain
network activity is not static but continuously changes as a function of
internal and external demands (Cocchi et al., 2013). These dynamic
patterns of activity may explain some of the response variability in
previous clinical studies of TMS in OCD (e.g., see Table 1 in Lefaucheur
et al., 2014). Constraining the mental state of participants using well-
designed behavioural tasks will allow for a customised TMS interven-
tion designed to target speciﬁc patterns of neural activity linked to
distinct aspects of OCD pathophysiology.
3.2. Toward an eﬀective modulation of OCD networks
As outlined above, context dependent variability of network activity
in OCD may play a signiﬁcant role when determining an appropriate
site for TMS interventions. We propose two key factors to consider
when designing a symptom-directed TMS intervention; 1) whether the
TMS is delivered at rest or during active engagement in a mental task;
and 2) the customization of the optimal cortical region to target.
Stimulation in a state of rest draws support from the preceding
resting-state fMRI studies that highlighted fronto-striatal hyper-con-
nectivity in patients with OCD compared to matched healthy controls
(e.g., Harrison et al., 2009). Therefore, there is an empirical rationale to
selectively target the regions that compose resting-state fronto-striatal
networks in patients with OCD. The observed hyper-activity of fronto-
striatal resting-state networks in OCD also suggests that inhibitory sti-
mulation may be appropriate to reduce the abnormal activity of OCD
frontostriatal networks. Administering TMS in a state of rest also pre-
sents several practical advantages, including the simple instructions to
patients (i.e., “please look at the ﬁxation cross in front to you, relax, and
avoid focusing on any particular thoughts”), and eschewing the need to
learn a potentially challenging behavioural task. Furthermore, for the
purposes of demonstrating a pre- vs post-TMS intervention analysis of
brain activity, resting-state acquisitions are short and simple.
The majority of TMS trials in OCD have targeted frontal and pre-
frontal brain regions encompassing fronto-striatal networks (Sachdev
et al., 2007; Gomes et al., 2012; Elbeh et al., 2016; Mantovani et al.,
2013; Berlim et al., 2013; Pedapati et al., 2015; Sarkhel et al., 2010)
(Table 1). However, the mental state of patients during application of
TMS in these studies does not appear to have been carefully considered
(Table 1). This lack of standardization may contribute to the large
variability of the eﬀects across studies and patients in the response to
TMS interventions (Lefaucheur et al., 2014; Dunlop et al., 2016)
(Table 1). Future studies adopting clear, standarised instructions for
patients to undertake during the stimulation may reduce the response
variability across subjects and trials, and may increase the clinical ef-
ﬁcacy of the intervention.
Processing of an external stimulus is state-dependent – that is, the
evoked brain activity depends on the pre-stimulus state of the neural
system (Hanslmayr et al., 2007; Hipp et al., 2011; Cocchi et al., 2017).
Evidence suggests that the brain spontaneously transitions between a
number of dynamic spatiotemporal states, even at rest (Ghosh et al.,
2008; Deco and Jirsa, 2012; Zalesky et al., 2014; Vidaurre et al., 2017;
Cocchi et al., 2017). The precise state of the brain when TMS is deliv-
ered — particularly the target network — can therefore impact its ef-
ﬁcacy, particularly for repetitive TMS protocols aiming to persistently
modulate neural activity (Silvanto et al., 2008; Polanía et al., 2018).
Administering TMS during constrained task conditions has therefore the
potential to enhance the magnitude and precision of the desired eﬀect.
For example, bursts of high intensity TMS (vs low intensity) on the left
resting motor cortex reduced the neural activity of the contralateral
motor cortex. On the other hand, the same stimulation while partici-
pants performed an isometric contraction of the left hand caused an
increase in neural activity in the right motor cortex (Bestmann et al.,
2008). Task-based TMS (single pulse, short bursts, or repetitive) has
therefore the potential to explicitly target symptom-speciﬁc neural
deregulations, including circuits associated with hoarding symptoms
Fig. 2. A Patterns of activity during transitions (highlighted in red in the
bottom diagram) from resting-state (R) to external task performance
[C= congruent trials and I= incongruent trials in the Multisource Interference
Task, (Bush and Shin, 2006)]. In both healthy and OCD patient groups, tran-
sition periods were associated with activity in the dorsal anterior cingulate
cortex, anterior insula, frontal operculum, substantia nigra, dorsal pons, left
globus pallidus, occipital and parietal cortices. B. Patients with OCD showed
additional activations in the thalamus, subthalamic nuclei, putamen, posterior
insula, intraparietal, premotor/motor cortex and cerebellum. C. A contrast
between the two groups showed greater activity in the right posterior insula,
superior temporal gyrus and anterior insula-frontal operculum in OCD com-
pared to controls. Reproduced with permission from (Cocchi et al., 2012b).
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(Tolin et al., 2012) and OCD symptom dimensions (Harrison et al.,
2013). To date, the use of carefully designed behavioural tasks to se-
lectively target dimensional or symptom-evoked brain network dereg-
ulations in OCD has been limited (e.g., Pedapati et al., 2015). Pro-
spective clinical studies will beneﬁt from a deeper understanding of the
physiological and cognitive factors underpinning the selective response
of task-evoked brain activity and connectivity to given TMS protocols
(Bestmann et al., 2008; Bestmann et al., 2010; Feredoes et al., 2011).
The combined use of TMS, particularly of repetitive protocols and be-
havioural tasks, will also require the assessment of the safety proﬁle of
such interventions in OCD.
In keeping with the aforementioned state eﬀects, metaplastic prin-
ciples can be used to predict and explain speciﬁc changes in local neural
activity (for a review see Müller-Dahlhaus and Ziemann, 2015). Meta-
plasticity is a broad term encompassing a series of endogenous neural
processes linked to activity-dependent synaptic plasticity. The inﬂu-
ential Bienenstock-Cooper-Munro theory [BCM, (Bienenstock et al.,
1982)], postulates that long term depression (LTD) is facilitated by
high levels of preceding postsynaptic activity, whereas long term po-
tentiation (LTP) is facilitated by low levels of recent postsynaptic ac-
tivity. In agreement with this theory, Doeltgen and Ridding (2011)
showed that priming cTBS with iTBS increases the LTD-like plasticity.
These results have been replicated, and extended to iTBS, by Murakami
et al. (2012). In addition to decreasing the variability of TMS eﬀects,
metaplasticity can facilitate the likelihood of obtaining synaptic
changes in local circuits aﬀected by OCD. Metaplasticity also refers to
changes occurring on longer time scales (hours-to-weeks) possibly via
subtle morphological synapto-dendritic changes. Such forms of meta-
plasticity may be relevant in planning the timing between TMS inter-
ventions and other therapies, including behavioural interventions
(Tsagaris et al., 2016).
Patients with OCD undergoing TMS are frequently managed with
concomitant pharmacotherapies. Many psychotropic medications, such
as SSRIs, are known to modulate the activity of the central nervous
system in OCD (Saxena et al., 2002; Nakao et al., 2005; Shin et al.,
2014). It is therefore important to account for the eﬀects of such psy-
chotropics on brain activity, at rest and during active task engagement.
Considering the eﬀect of medication on given neural circuits can also
oﬀer the potential to eﬀectively complement pharmacological inter-
ventions with TMS. Seminal work by Saxena et al. (2002) showed that
12 weeks of paroxetine hydrochloride treatment in OCD reduced glu-
cose metabolism in the right caudate nucleus, right putamen, thalamus,
right ventrolateral prefrontal cortex and bilateral orbitofrontal cortex.
The reductions in the right putamen, caudate and thalamus occurred
only in OCD patients that responded to the pharmacological interven-
tion (i.e., 25% reduction in YBOCS scores as well as “very much” im-
proved on a clinical scale). This ﬁnding supports the notion that OCD
symptoms are linked to abnormal activity in the prefrontal-striatal-
thalamic networks. Because higher doses of SSRIs (e.g., 60mg/d of
paroxetine hydrochloride) may not be tolerated, inhibitory TMS on the
orbitofrontal cortex may facilitate the reduction of activity in the pre-
frontal-striatal-thalamic networks, enhancing the eﬀect of medication
in non-responders or reducing the dose required in those who do re-
spond.
A second factor to consider when designing a TMS trial for OCD is the
selection of the optimal cortical region to target. To date, the choice of sti-
mulation site in OCD patients is predicated on approved protocols to treat
medication-resistant MDD, resting-state neuroimaging work in OCD
(Harrison et al., 2009; Harrison et al., 2013), and existing knowledge on
fronto-striatal functional and anatomical connectivity (e.g., Sachdev et al.,
2007). Accordingly, the large majority of existing studies have targeted the
DLPFC (right, Gomes et al., 2012; left, Prasko et al., 2006), the supplementary
motor area [SM, (Mantovani et al., 2010; Mantovani et al., 2013)], and the
OFC (Ruﬃni et al., 2009; Nauczyciel et al., 2014). The results of these studies
have been inconclusive for the DLPFC, with limited evidence supporting the
stimulation of this region to alleviate symptoms of OCD (Slotema et al., 2010;
Berlim et al., 2013; Lefaucheur et al., 2014). This outcome could be explained
by the fact that whereas the DLPFC has been implicated in the cognitive
eﬀects of MDD, abnormalities in DLPFC-striatal connectivity have not been
consistently reported in resting-state studies of OCD. However, context-de-
pendent stimulation of the DLPFC in OCD may provide eﬃcacy; namely,
stimulation during the presentation of symptom-provoking stimuli. On the
other hand, data from preliminary studies targeting the SMA or the prefrontal
cortex are more encouraging [e.g, (Mantovani et al., 2010; Mantovani et al.,
2013; Ruﬃni et al., 2009), Table 1], but these need to be replicated in well-
powered, double-blind, clinical trials. In addition to their limited number and
small sample size, existing TMS studies in OCD rarely use structural magnetic
resonance imaging data to deﬁne the target region for stimulation persona-
lized to the patient's own neuroanatomy. Compared to a commonly used
scalp-based localization technique (localization of the best cortical site for
activating a hand muscle, generally the abductor pollicis brevis, and then 5 cm
anteriorly along the scalp surface), the use of neuronavigation to target a
speciﬁc cortical site has been shown to signiﬁcantly enhance the eﬃcacy of
TMS intervention in treatment resistant major depression at 4weeks
(p < 0.02) (Fitzgerald et al., 2009). Likewise, the optimal angle of stimu-
lation [i.e., coil handle perpendicular to the crown of the targeted gyrus,
(Thielscher et al., 2011; Richter et al., 2013)] is not adapted to each in-
dividual's neuroanatomy, increasing the variability in the response to sti-
mulation (Thielscher et al., 2011; Opitz et al., 2013; Cocchi and Zalesky,
2018). Non-optimal angles of stimulation are less likely to eﬀectively and
directly modulate cortical activity and cortico-cortical connectivity
(Thielscher et al., 2011; Opitz et al., 2013). Biophysical models of magnetic
ﬂux and current ﬂow through skull, dura and cortex informed by patient-
speciﬁc neuroimaging data provide a means to computationally simulate the
impact of coil placement with respect to individual neuroanatomy. This ap-
proach could potentially be used to further personalize TMS delivery in OCD
(Opitz et al., 2013).
New advances in psychiatric research suggest that the functional ar-
chitecture of whole-brain networks can be used to parse patients' clinical
heterogeneity and optimise the selection of TMS targets (Drysdale et al.,
2017; Lin et al., 2018; Cocchi and Zalesky, 2018). In particular, a recent
study including a large sample of patients with depression (n=1188) has
suggested that patients can be divided into four distinct clusters based on
their distinct patterns of resting-state functional connectivity in limbic and
frontostriatal networks (Drysdale et al., 2017). This study showcases the
exciting new avenues to improve the eﬃcacy of TMS interventions by
personalizing interventions based on neurophysiological measures [see also
(Lin et al., 2018)]. The use of neuroimaging-guided TMS presents several
challenges in everyday clinical settings, including higher costs compared to
standard interventions and expertise in neuroimaging and TMS neurona-
vigation. Ultimately, should future work conﬁrm that the utility of TMS
interventions for OCD relies upon such detailed pre-treatment assessments,
then modelling by health economists will be required to determine whether
it is cost eﬀective in clinical practice.
4. Outstanding issues
Studies on the role of TMS in the treatment for OCD symptoms are so far
limited. Moreover, the large majority of existing studies include small
samples, use diﬀerent stimulation parameters and cortical targets, do not
standardise the context in which TMS is administered, and do not take
advantage of imaging-guided TMS (neuronavigation). Therefore, there is a
pressing need for new studies addressing the possible use of TMS as an
eﬃcacious and cost-eﬀective therapeutic intervention for OCD. The use of
TMS to eﬀectively restore brain network dynamics and reduce symptoms of
OCD may also beneﬁt from a deeper understanding of how a focal per-
turbation of neural activity impacts activity in, and functional connectivity
between, remote brain regions (Eldaief et al., 2011; Cocchi et al., 2015;
Cocchi et al., 2016; Gollo et al., 2017; Ruﬀ et al., 2006; Sale et al., 2015).
Without this knowledge, the planning and outcome prediction of TMS in-
terventions remain diﬃcult and the development of new therapeutic pro-
tocols will be dependent on ineﬃcient and costly trial and error approaches.
L. Cocchi et al. NeuroImage: Clinical 19 (2018) 661–674
665
In the past ﬁve years, the modelling of altered brain network ac-
tivity in OCD using neuroimaging data has grown substantially
(Bandelow et al., 2016). Neuroimaging studies have shown a relation-
ship between brain activity and symptoms in OCD but causality has yet
to be determined. For example, the key role of activity within the
prefrontal cortex for OCD symptoms has been highlighted by several
resting-state studies (Harrison et al., 2009; Hou et al., 2014; Sakai et al.,
2011; Figee et al., 2013; Morgiève et al., 2014). These studies suggest
that a selective inhibition of the prefrontal (e.g., OFC) hyper-activity
may reduce OCD symptom severity. However, these studies do not
preclude the possibility that prefrontal hyper-activity may be linked to
neurophysiological and/or cognitive compensatory mechanisms: In-
hibiting this region could therefore worsen OCD symptoms. The link
between symptoms and observed changes in brain activity and con-
nectivity is not always straightforward and the potential modulating
eﬀect of TMS on this association requires careful consideration.
The neural principles underlying the eﬀect of local TMS on distant brain
regions are not fully understood. Addressing this is an important prelude to
predicting how a local perturbation will impact upon the brain network
dynamics implicated in OCD. For example, the OFC and the striatum, par-
ticularly the ventral striatum, are functionally interconnected at rest (Jaspers
et al., 2017). Results from recent studies combining TMS and fMRI support
the notion that local stimulation of a cortical region in the resting-state has
greater impact on the functional connectivity between the target region and
remote regions composing the same functional network (Eldaief et al., 2011;
Cocchi et al., 2016). Therefore, inhibition of the OFC in a state of rest is
expected to result in a signiﬁcant reduction of functional connectivity within
the striatum. However, while mainly circumscribed within a deﬁned func-
tional network, the impact of local TMS to the dynamic interplay between
brain regions may “spill” over into regions belonging to brain networks not
directly targeted by the stimulation (Cocchi et al., 2015; Gollo et al., 2017).
The nature and implication of these “secondary” eﬀects on brain dynamics to
clinical interventions remain to be established.
In addition to the presence of functional connectivity changes, pre-
dicting the direction of changes in connectivity is also an active ﬁeld of
research. Recent work challenges the notion of a simple linear association
between increases or reductions in local brain activity and changes in
functional connectivity (Gollo et al., 2017; Cocchi et al., 2016). Studies have
suggested that neural activity in highly interconnected brain regions [brain
hubs, (van den Heuvel and Sporns, 2013)] is characterised by slower
ﬂuctuations in spiking activity (longer temporal receptive ﬁeld) compared
to peripheral regions such as the primary visual cortex (Baldassano et al.,
2017; Murray et al., 2014; Gollo et al., 2015; Hasson et al., 2015; Hasson
et al., 2008). In this sense, the intrinsic timescale of hub regions is slower
than peripheral regions. Results from studies combining neuroimaging,
TMS, and computational modelling support this temporal organization of
the brain, showing that the impact of local stimulation to whole-brain
patterns of communication between brain regions can be predicted by a
cortical hierarchy of timescales (Gollo et al., 2017; Cocchi et al., 2016).
Without valid predictive models, the targeted use of TMS to restore net-
work dynamics in brain disorders relies solely on empirical work, which can
be expensive and prone to ad hoc trial and error.
A further challenge to improving the likelihood of selectively mod-
ulating altered brain network activity in OCD is the inter- (Hamada et al.,
2013; Dunlop et al., 2016) and intra-subject (Sale et al., 2007) variability in
the local response to TMS. This variability has been linked to several factors
including age (Rogasch et al., 2009), genetic inﬂuences (Antal et al., 2010;
Kleim et al., 2006) and hormones (Sale et al., 2008). Studies have also
highlighted the dynamic nature of functional brain connectivity in states of
rest and external task (Cocchi et al., 2017; Hearne et al., 2017; Zalesky
et al., 2014; Shine et al., 2016), suggesting that the time in which the sti-
mulation is performed could impact the propagation of the local pertur-
bation throughout the brain. Future research is needed to better understand
the variability of TMS and allow eﬀects that are more consistent across
stimulation sessions and patients.
Finally, the translation of approaches combining computational
modelling, advanced neuroimaging analysis, and behavioural tools that
constrain mental states into the clinic presents signiﬁcant practical
challenges. In addition to technical advances streamlining data mod-
elling, the eﬀective implementation of the proposed multimodal ap-
proach will require multidisciplinary clinical teams. Such multi-
disciplinary planning of therapeutic interventions is common in other
technologically-based medical disciplines (e.g., brain oncology).
5. Summary and recommendations
In concluding, we propose a summary of the state of research in this
ﬁeld and practical recommendations to improve the reliability of TMS
interventions for OCD. While these recommendations are speciﬁc to
OCD interventions, a number of them may be applicable to stimulation
protocols used to treat symptoms of diﬀerent brain disorders:
• Whether TMS can eﬀectively normalise brain activity underpinning
OCD symptoms has yet to be established by clinical trials.
• Theoretical and empirical advances in network neuroscience suggest
that improving the eﬃcacy of TMS for OCD is contingent on the
mapping of altered whole-brain patterns of neural activity in OCD.
Progress in the understanding of principles supporting how local
TMS aﬀects the activity within, and connectivity between, remote
brain regions appears key to the development of new eﬀective TMS
interventions for OCD.
• Neuroimaging, TMS, and computational modelling may help the
identiﬁcation of optimal stimulation targets to normalise the ac-
tivity of deﬁned neural networks underpinning OCD symptoms. The
eﬃcacy and practical implementation of this complex multimodal
approach will need to be assessed by future clinical trials.
• Altered brain network activity in OCD is state-dependent. In a state
of rest, OCD symptoms have been linked to increased functional
connectivity strength between the striatum and the prefrontal cortex
[e.g., (Harrison et al., 2009)]. Therefore, if delivered at rest, in-
hibitory stimulation of the orbitofrontal and frontal pole regions
holds the greatest potential to signiﬁcantly improve symptoms.
Stimulation of prefrontal regions can result in discomfort and thus,
short protocols such as cTBS are preferred. While stimulation of
DLPFC in OCD is not recommended in the resting-state, new evi-
dence suggests that sessions of inhibitory TMS of this region during
the viewing of symptom-provoking stimuli may facilitate the re-
sponse to subsequent cognitive behavioural therapy (Olatunji et al.,
2014). Overall, these preliminary ﬁndings support the notion that
the eﬀects of TMS are context dependent and aﬀected by con-
comitant therapeutic interventions. We have presently discussed
personalizing TMS according to an individual's functional con-
nectivity and clinical proﬁle, but in the future, it may be possible to
further personalize TMS by administering stimulation during the
presentation of personalized stimuli that elicit individually-speciﬁc
responses.
• The impact of psychotropic medication should be considered when
planning TMS interventions. TMS could be used to facilitate the
response to medication where dose increases for the patient are not
possible. Such an approach is consistent with the broader notion
that combination therapies may be more eﬀective than either
therapy in isolation.
• The use of neuroimaging-guided neuronavigation can assist with the
precise modulation of neural activity and connectivity underpinning
symptoms of OCD. The consideration of anatomical individual dif-
ferences is likely to improve the eﬃcacy and reliability of TMS as a
therapeutic intervention [e.g., (Fitzgerald et al., 2009)].
• Individually tailored TMS that accounts for network mechanisms
and state dependence may be a viable treatment modality for pa-
tients not suitable for pharmacological or behavioural therapies.
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Glossary
Electromagnetic induction: TMS use principles of electromagnetic induction to induce an
electrical ﬁeld suﬃcient to depolarize cortical axons.:
Functional connectivity: A measure of statistical dependence between neural signals recorded
in diﬀerent brain regions. Functional connectivity can be assessed using non-invasive
neuroimaging techniques including fMRI. However, functional connectivity is agnostic re-
garding the causal interactions between brain regions and does not imply direct anatomical
connections between them.:
Functional magnetic resonance imaging (fMRI): A common method to infer neural activity
non-invasively. The blood‑oxygen-level dependent (BOLD) contrast signal measured using
fMRI reﬂects changes in the proportion of oxy- and deoxygenated blood in a localised brain
region (within a few millimeters) arising from neurovascular coupling. The temporal re-
solution of fMRI is in the order of seconds, capturing only a portion of neural dynamics.:
Hub: A region that possesses a large number of connections with other regions of the brain.
Hubs are deﬁned by measures of network centrality (e.g., degree).:
Long-term potentiation (LTP): Facilitation of neural transmission due to a long-lasting in-
crease in the synaptic strength. Long-term depression (LTD) refers to the opposite phe-
nomenon. The persistent eﬀects of repetitive TMS and TBS protocols are thought to rely on
LTP and LTD mechanisms.:
Motor evoked potentials (MEP): Electrical responses measured from superﬁcial muscles in
response to TMS of the brain motor cortex. MEPs are used to establish intensity of repetitive
TMS and assess its eﬀects when the motor system is targeted.:
Plasticity: Refers to the ability of the brain to change the properties of local neural circuits and
larger brain networks. The mechanisms of action of several transcranial magnetic stimu-
lation paradigms, including continuous theta burst stimulation (cTBS), rely on neural
plasticity.:
Predictive models: Statistical and biophysical models to predict the likelihood of a given
outcome. Predictive models can be used to optimise TMS parameters in order to achieve a
precise modulation of neural network activity underpinning the symptoms of OCD.:
Resting-state: A common approach to assessing functional connectivity involves measuring
brain activity while participants are in a state of rest. In a typical resting-state protocol,
individuals are asked to remain awake and not engage in any particular task or mental
activity. Correlations between low-frequency (< 0.1 Hz) resting-state BOLD signal across
brain regions has been related to a fundamental property of brain organization, predicting
neural dynamics and behaviours observed in task contexts (Smith et al., 2015; Cole et al.,
2016). Resting-state studies have also highlighted associations between neural network
activity at rest and symptoms of psychiatric disorders, including OCD (Harrison et al.,
2009).:
Theta burst stimulation (TBS): Is a form of repetitive TMS that induces long-lasting changes in
corticospinal excitability via long-term potentiation (LTP) and depression (LTD). TBS in-
volves the delivery of 3 pulses of stimulation given at 50 Hz.:
Continuous theta burst stimulation (cTBS): Delivers an uninterrupted train of theta bursts. A
common example is a 40 s train (600 pulses in total). This paradigm causes a reduction of
local cortical excitability (Huang et al., 2005) and changes in functional connectivity
between remote brain regions (Cocchi et al., 2015) that outlast the period of stimulation.:
Intermittent theta burst stimulation (iTBS): Is a two second train of theta bursts repeated every
10 s for 190 s (600 pulses) (Huang et al., 2005). This protocol has opposing eﬀects to
cTBS. The predicted after-eﬀects of TBS are, however, variable (Hamada et al., 2013).
TBS protocols have recently been validated to treat symptoms of major depression
(Blumberger et al., 2018) but their eﬃcacy in treating OCD symptoms remains unclear.:
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